Patent: 10,034,938
✉ Email this page to a colleague
Summary for Patent: 10,034,938
Title: | Method for treating melanoma using a herpes simplex virus and an immune checkpoint inhibitor |
Abstract: | The invention relates to methods of treating melanoma using a herpes simplex virus in combination with an immune checkpoint inhibitor. |
Inventor(s): | Vanderwalde; Ari (Memphis, TN), Shabooti; Mohamed (Agoura Hills, CA) |
Assignee: | Amgen Inc. (Thousand Oaks, CA) |
Application Number: | 14/424,424 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,034,938 |
Patent Claims: | see list of patent claims |
Details for Patent 10,034,938
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bristol-myers Squibb Company | YERVOY | ipilimumab | Injection | 125377 | 03/25/2011 | ⤷ Try a Trial | 2032-08-30 |
Amgen, Inc. | IMLYGIC | talimogene laherparepvec | For Injection | 125518 | 10/27/2015 | ⤷ Try a Trial | 2032-08-30 |
Bristol-myers Squibb Company | OPDIVO | nivolumab | Injection | 125554 | 12/22/2014 | ⤷ Try a Trial | 2032-08-30 |
Bristol-myers Squibb Company | OPDIVO | nivolumab | Injection | 125554 | 10/04/2017 | ⤷ Try a Trial | 2032-08-30 |
Bristol-myers Squibb Company | OPDIVO | nivolumab | Injection | 125554 | 08/27/2021 | ⤷ Try a Trial | 2032-08-30 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |